Playtech plc (LON:PTEC – Get Free Report) insider Mor Weizer acquired 71,321 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were bought at an average cost of GBX 375 per share, for a total transaction of £267,453.75.
Playtech Stock Up 0.5%
Shares of Playtech stock traded up GBX 1.80 during trading hours on Wednesday, reaching GBX 365. 71,807,813 shares of the company were exchanged, compared to its average volume of 12,699,473. Playtech plc has a 1 year low of GBX 210 and a 1 year high of GBX 447. The stock’s fifty day moving average is GBX 367.84 and its 200 day moving average is GBX 315.52. The company has a debt-to-equity ratio of 24.36, a quick ratio of 1.09 and a current ratio of 1.42. The firm has a market cap of £1.01 billion, a PE ratio of 0.75, a PEG ratio of 1.28 and a beta of 0.65.
Playtech announced that its board has authorized a share repurchase program on Friday, March 27th that authorizes the company to buyback 5,660,000 outstanding shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on PTEC
About Playtech
Playtech plc, a technology company, provides gambling software, services, content, and platform technologies worldwide. The company offers technologies across various product verticals, including live casino, sports, bingo, virtual sports, and poker. It also owns the intellectual property rights and licenses the software; provides digital marketing and advertising, consulting and online technical support, data mining processing, turnkey, live game, and video stream services; and operates betting shops.
Featured Stories
- Five stocks we like better than Playtech
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
- The Great AI Rotation: Cashing In on Data
- Mirum Pharma: A Rare Disease Growth Story to Watch
Receive News & Ratings for Playtech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Playtech and related companies with MarketBeat.com's FREE daily email newsletter.
